Allergic bronchopulmonary aspergillosis in children
CONCLUSION: Today, although risk factors have been investigated for ABPA, it has not been revealed clearly. Both diagnostic criteria and treatment regimens have been described in research studies, mostly adults. In pediatric patients; clarification of diagnosis and treatment algorithms is necessary to prevent irreversible lung tissue damage and possible drug side effects.PMID:34174797 | DOI:10.3906/sag-2104-227
Source: Turkish Journal of Medical Sciences - Category: General Medicine Authors: Özge Atay Suna Asilsoy Gizem Atakul Serdar Al Özge Kangalli Boyacioğlu Nevin Uzuner Özkan Karaman Source Type: research
More News: Allergy | Allergy & Immunology | Aspergillosis | Aspergillus | Asthma | Children | Corticosteroid Therapy | General Medicine | Laboratory Medicine | Pediatrics | Study | Turkey Health